Key Insights
- Ferro-aging is a newly defined aging process characterized by iron accumulation, oxidative lipid degradation (aka lipid peroxidation), and a specific type of iron-dependent cell death called ferroptosis.
- Researchers identified the fatty acid-activating enzyme ACSL4 as the primary driver of this process in primates, showing that its expression levels rise significantly in aging organs like the liver and kidneys.
- The study found that Vitamin C acts as a direct inhibitor of ACSL4, a new role of Vitamin C in addition to its antioxidant function.
- This suggests that maintaining optimal Vitamin C levels may be a critical, low-cost strategy to prevent ‘iron-rusting’ of our vital organs as we age.
Ferro-aging or ‘Iron Rust’ theory of primate aging
Scientists have known for years that aging is often accompanied by a mysterious accumulation of iron in our tissues, but the exact consequences of this remained unclear. This study, published in Cell Metabolism in April 2026, introduces the concept of ferro-aging a state where excess iron in cells leads to the destruction of cell membranes through ferroptosis an iron-dependent cell death. This process is particularly damaging because it doesn’t just kill cells; it drives a self-reinforcing cycle of chronic inflammation and tissue scarring. While humans and other primates have evolved complex systems to manage cells iron-load, these control mechanisms slowly fray over time. The result: higher cellular iron accumulation in organs, upregulation of the lipid-activating enzyme ACSL4, damage to cell membrane lipids and organ and overall aging.
The article found that:
- Primate Ferro-aging Map: By analyzing tissue from young and old Cynomolgus monkeys, researchers found that aging organs exhibit high iron deposits, lipid damage, and signature of iron-induced cell death.
- ACSL4 enzyme acts as the ferrro-aging master switch: High ACSL4 in young primate cells accelerated cellular senescence (cell aging), while lowering it in old cells reversed many aging markers.
- A new role for Vitamin C: The researchers tested 100 different molecules to see they can prevent or slow down ferro-aging. The team discovered that Vitamin C directly binds to the active site of ACSL4 enzyme, preventing it from processing the fats needed for ferroptosis.
- Supplementation success in primates: Aging monkeys given long-term (40 month), high-dose Vitamin C supplementation showed a significant reduction in age-related elevation in plasma ferrous-iron, lowered ferro-aging markers across many organs and tissues.
- Vitamin C reversed biological aging in organs and organ functions: Multi-omic aging clocks showed lower biological aging across many organs including the brain, muscle, fat, skin, kidney, pancreas and the aorta. Remarkably, Vitamin C supplementation slowed brain-atrophy, lowered triglycerides, elevated good cholesterol (HDL-C), improved glucose-tolerance, and reduces age-related visceral fat.
Vitamin C supplementation may reduce biological aging and slow down age-related organ decline
This study provides fresh insight into the role of Vitamin C, moving it beyond the generic immune-booster and anti-oxidant and into the category of a senotherapeutic with a previously unknown mechanism of action. Most interestingly, beyond the lowering of biological organ aging, the data suggests functional and metabolic benefits across many organs. The fact that this study was done on primates should increase confidence that the findings may be applicable to humans.
The monkey study was done with 30 mg/kg oral dose, which when converted to human equivalent dose is roughly 10mg/kg. Converting this to a 170 lb to 180 lb adult (~77 to 82 kg), we would need to dose 770 to 820 mg or roughly 800 mg of Vitamin C per day. The NIH Office of Dietary Supplements states that the tolerable upper intake level for Vitamin C for an adult 19+ is 2000 mg/day. There are however some concerns around formation of kidney stones and excess iron absorption with high Vitamin C intake. But these are not considered risk factors for healthy people.
Liu, L., Zheng, Z., You, W., Yang, P., Wen, Y., Qiao, Y., Ma, S., Zhang, H., Zhang, S., Xu, G., Ma, C., Tian, A., Jiang, M., Zhang, T., Geng, L., Li, J., Sun, X., Wang, F., Xiong, M., Yang, Y., Lu, X., Jiang, X., Dong, X., Zhang, Z., Huang, Y., Zhang, B., Qiao, Q., Sun, S., Fan, Y., Cai, Y., Yan, K., Zhang, Y., Jing, Y., Jing, Y., Wang, Q., Lei, J., Tan, A., Han, Z., Reddy, P., Haghani, A., Rodriguez Esteban, C., Zhang, F., Liu, Z., Liu, N., Wang, S., Horvath, S., Yang, J., Izpisua Belmonte, J. C., Zhang, W., Qu, J., & Liu, G.-H. Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates. Cell Metabolism. 2026;38(4):673–693.e17. https://doi.org/10.1016/j.cmet.2026.02.010
Dixon, S. J., & Olzmann, J. A. The cell biology of ferroptosis. Nature Reviews Molecular Cell Biology. 2024;25:424–442. https://doi.org/10.1038/s41580-024-00703-5
Dixon, S. J., & Pratt, D. A. Ferroptosis: a flexible constellation of related biochemical mechanisms. Molecular Cell. 2023;83(7):1030–1042. https://doi.org/10.1016/j.molcel.2023.03.005
Vitamin C: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/